, as reported in our previous study 1 . Consequently, VSMCs within blood vessel wall express high level of hnRNPA1 and maintain its contractile phenotype. On the other hand, in response to atherogenic stimuli [e.g. vascular injury, cardiovascular (CV) risk factors, inflammation, high serum, PDGF-BB, oxidized low-density lipoprotein (oxLDL)], hnRNPA1 expression in VSMCs or injured arteries is inhibited. Decreased hnRNPA1 up-regulates IQGAP1 through two mechanisms (modulating miR-124 biogenesis, and miR-124 and hnRNPA1/ARE binding site within 3'UTR of IQGAP1). Increased IQGAP1 promotes VSMC proliferation and migration, resulting in neointima formation.
